Effect of serotype on focus and mortality of invasive pneumococcal disease: Coverage of different vaccines and insight into non-vaccine serotypes

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  van Hoek, Albert Jan ^a   Andrews, Nick ^a   Waight, Pauline A ^a   George, Robert ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EMPYEMA; FATALITY; HOSPITAL ADMISSION; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MENINGITIS; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEPSIS; SEROTYPE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; HUMANS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SEROTYPING; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84864006264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039150     Document Type: Article

References (27)

1. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, et al. (2006) Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS genetics 2: e31 doi:10.1371/journal.pgen.0020031.
2. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, et al. (2006) Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. The Journal of infectious diseases 194: 682-8 doi:10.1086/505710.
3. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, et al. (2011) Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS medicine 8: e1001017 doi:10.1371/journal.pmed.1001017.
4. Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, et al. (1996) Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clinical infectious diseases 22: 973-81.
5. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clone-specific differences in invasive disease potential. Journal of Infectious Diseases 187: 1424.
6. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, et al. (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS medicine 6: e1000081 doi:10.1371/journal.pmed.1000081.
7. Weinberger DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, et al. (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clinical infectious diseases 51: 692-9 doi:10.1086/655828.
8. Jansen AGSC, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, et al. (2009) Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clinical infectious diseases 49: e23-9 doi:10.1086/600045.
9. Cheung Y-B, Zaman SMA, Nsekpong ED, Van Beneden CA, Adegbola RA, et al. (2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. The Pediatric infectious disease journal 28: 990-5 doi:10.1097/INF.0b013e3181a78185.
10. Spijkerman J, van Gils EJM, Veenhoven RH, Hak E, Yzerman F, et al. (2011) Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands. Emerging Infectious Diseases 17: 584-591 doi:10.3201/eid1704101115.
11. Miller E, Andrews NJ, Waight PA, Slack MP, George RC, (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. The Lancet infectious diseases 11: 760-768 doi:10.1016/S1473-3099(11)70090-1.
12. World Health Organisation (2011) Review of Serotype Replacement in the Setting of PCV7 Use and Implications for the PCV10/PCV13 Era. Available:http://www.who.int/immunization/sage/SAGEReplacementReport2011FINAL_nov11.pdf. Accessed 2012 Feb 14.
13. Miller E, Andrews NJ, Waight PA, Slack MPE, George RC, (2011) Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 29: 9127-9131 doi:10.1016/j.vaccine.2011.09.112.
14. Healthcare cost and Utilization Project (2012) Clinical classifications. Available:http://www.hcup-us.ahrq.gov/toolssoftware/icd_10/ccs_icd_10.jsp. Accessed 2012 Jun 14.
15. Bennett JE, Sumner W, Downs SM, Jaffe DM, (2000) Parents' utilities for outcomes of occult bacteremia. Archives of pediatrics & adolescent medicine 154: 43-8.
16. Jit M, (2010) The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. The Journal of infection 61: 114-24 doi:10.1016/j.jinf.2010.04.008.
17. Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA, (2008) Necrotising pneumonia is an increasingly detected complication of pneumonia in children. The European respiratory journal 31: 1285-91 doi:10.1183/09031936.00099807.
18. National Office for Statistics (2011) Interim Life Tables, 2008-2010. Available:http://www.ons.gov.uk/ons/rel/lifetables/interim-life-tables/2008-2010/rft-ilt-ew-2008-2010.xls. Accessed 2012 Jun 14.
19. (2008) Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence. 76 p.
20. Department for Communities and Local Government (2011) The English Indices of Deprivation. Available:http://www.communities.gov.uk/publications/corporate/statistics/indices2010. Accessed 2012 Jun 14.
21. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, et al. (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of clinical epidemiology 57: 1288-94 doi:10.1016/j.jclinepi.2004.03.012.
22. Weinberger DM, Harboe ZB, Sanders E a M, Ndiritu M, Klugman KP, et al. (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clinical infectious diseases 51: 692-9 doi:10.1086/655828.
23. AlonsoDeVelasco E, Verheul A, Verhoef J, Snippe H, (1995) Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiological reviews 59: 591-603.
24. Elberse KEM, van de Pol I, Witteveen S, van der Heide HGJ, Schot CS, et al. (2011) Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing. PloS one 6: e20390 doi:10.1371/journal.pone.0020390.
25. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MCC, et al. (2007) Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. Journal of clinical microbiology 45: 1225-33 doi:10.1128/JCM.02199-06.
26. Burgos J, Lujan M, Falcó V, Sánchez A, Puig M, et al. (2011) The spectrum of pneumococcal empyema in adults in the early 21st century. Clinical infectious diseases 53: 254-61 doi:10.1093/cid/cir354.
27. GlaxoSmithKline Biologicals, (2011) Package insert Synflorix. 9. Available:http://www.who.int/immunization_standards/vaccine_quality/Synflorix_WHO_leaflet_EN_May_2011.pdf. Accessed 2012 Jun 14.